Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.35 HKD | +4.44% | +6.43% | +9.29% |
May. 15 | China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection | MT |
May. 14 | China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.29% | 8.44B | |
+23.92% | 74.5B | |
-2.46% | 24.24B | |
+10.52% | 8.45B | |
-21.71% | 7.65B | |
+11.90% | 5.24B | |
+2.27% | 4.14B | |
-4.23% | 3.95B | |
+5.42% | 3.83B | |
+22.54% | 3.56B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- UBS Adjusts Sinopharm's Price Target to HK$28 From HK$30, Keeps at Buy